Cluenex
Log inStart free
All stocks · Healthcare · Health Care Distributors

McKesson Corporation MCK

McKesson Corporation scores good on business quality (6.6 of 10). Here is why, in plain words, and what our sealed record shows.

Last price$938.84Oct 9, 2026
Business qualityGood
Next earningsNov 4, 2026
Insiders, 90 daysSelling

Why it matters

  1. What McKesson Corporation does

    McKesson distributes pharmaceuticals and provides medical supplies to healthcare providers at massive scale. Pharmacies, hospitals, and clinics pay for reliable, high-volume supply chain delivery.

  2. What it does best

    McKesson dominates pharmaceutical distribution through entrenched scale, matching a gross margin of 3.6% against dense logistics networks that smaller rivals cannot easily replicate.

  3. The main risk

    Tight operating margins leave the business vulnerable to any disruption in pharmaceutical pricing or distribution contracts, putting net income at risk from minor cost pressures.

Quality, check by check

Scored against its own industry, from company filings.

ProfitabilityWeak

Operating margin of 1.6% and net margin of 1.1% highlight razor-thin margins that do not expand significantly with scale.

MoatStrong

Scale creates a distribution moat locking in healthcare providers, though a gross margin in the bottom quartile of its sector reflects low pricing power.

GrowthFast

Revenue growth runs at 12.4%, accelerating from a historical base of $276B in 2023 to $410B in latest figures.

Financial healthStrong

Interest coverage sits at 23.8x, making debt service manageable while free_cash_flow reaches $6.1B, showing strong cash conversion.

Insiders

Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.

1 sold $269K outside pre-planned sales.

Our sealed record on MCK

Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.

The first sealed verdicts appear here on Oct 11, 2026.

Questions

Is MCK a good business?

McKesson Corporation scores good on the Cluenex quality check (6.6 of 10), measured against its own industry. Profitability is weak, moat strong, growth fast and financial health strong.

Are insiders buying MCK?

In the last 90 days of SEC Form 4 filings: 1 sold $269K outside pre-planned sales.

When does MCK report earnings?

Nov 4, 2026.

For members

See MCK today

  • Today's verdict on MCK, and why
  • Fair value with cautious, base and optimistic cases
  • The exact price that would change the verdict
  • Which stocks each signal names, the night it fires
Open in Cluenex Free to start. First month of Core free.

Cite this page: Cluenex, “McKesson Corporation (MCK)”, https://cluenex.com/stocks/mck/, data as of Oct 10, 2026.